Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Collins Promises To Send NCATS Funding Proposal To Congress Within Weeks

Executive Summary

National Institutes of Health Director Francis Collins expects to send, "in the fairly near future," detailed plans to Congress for shifting existing translational research projects into a new National Center for Advancing Translational Research.

You may also be interested in...



NIH Translational Center To Study Cell-Based Toxicity Tests, Offer Industry Grants

Toxicity testing is one area in which NIH Director Francis Collins expects the proposed National Center for Advancing Translational Science to help industry speed up drug development.

NIH Translational Center To Study Cell-Based Toxicity Tests, Offer Industry Grants

Toxicity testing is one area in which NIH Director Francis Collins expects the proposed National Center for Advancing Translational Science to help industry speed up drug development.

FDA Could Face 13% Funding Cut Under House FY '12 Appropriations Bill

House Republicans' proposal to cut funding in the fiscal year 2012 Agriculture/FDA appropriations bill by 13% would cost FDA about $475 million if it applied across the board to both USDA and FDA.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS053393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel